Published

Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Brain, behavior, and immunity
Date: 2023-11-01
Source: PubMed
DOI: 10.1016/j.bbi.2023.09.004
PubMed: 37689275

Authors

Mason NL Szabo A Kuypers KPC Mallaroni PA de la Torre Fornell R Reckweg JT Tse DHY Hutten NRPW Feilding A Ramaekers JG

Watch author

Derived topics and classifications

psilocybin Depression Mechanism of Action Biomarkers Healthy Volunteers Inflammation Immune Function Other

Citation graph

0 referenced DOIs found in stored source metadata. 10 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder2026-07-07 Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions2026-07-02 Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats2026-06-01 Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder2026-05-26 Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications2026-04-01 Pilot study of psilocybin in patients with post-treatment lyme disease2026-02-25 Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathway2025-10-01 Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling2025-06-01 Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner2024-10-28 Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study.2023-11-01

Related papers

Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10 Psilocybin in Alcohol Use Disorder With Comorbid DepressionClinicalTrials.gov · 2025-03-19 Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-08-12 An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult PatientsClinicalTrials.gov · 2024-05-08 PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin PretreatmentClinicalTrials.gov · 2026-07-21 14C-Psilocin tissue distribution in pregnant rats after intravenous administrationFunctional Foods in Health and Disease · 2014-07-27 Effects of psilocybin on the human brain functional networkFigshare · 2012-12-31 Probing the Functional Magnetic Resonance Imaging Response to Psilocybin in Functional Neurological Disorder (PsiFUND)ClinicalTrials.gov · 2026-07-23